Immunoglobulin G from breast cancer patients in stage i stimulates muscarinic acetylcholine receptors in MCF7 cells and induces proliferation. Participation of nitric oxide synthase-derived nitric oxide

Journal of Clinical Immunology

Volumn 30, Issue 3, 2010, Pages 474-484

  Negroni, María Pía ^a   Fiszman, Gabriel L ^b   Azar, María E ^b   Morgado, Carlos Cresta ^b   Español, Alejandro J ^a   Pelegrina, Laura T ^a   De La Torre, Eulalia ^a   Sales, María Elena ^a  

^a Centre de Estudios Farmacologicos y Botanicos   (Argentina)

^b UNIVERSIDAD DE BUENOS AIRES   (Argentina)

Author keywords

Autoantibodies; MAChR; MCF 7 breast cancer cells; Nitric oxide; Proliferation

Indexed keywords

AGAROSE; IMMUNOGLOBULIN G; MUSCARINIC M3 RECEPTOR; MUSCARINIC M4 RECEPTOR; MUSCARINIC RECEPTOR; NITRIC OXIDE SYNTHASE; PHOSPHOLIPASE C; AUTOANTIBODY; CARBACHOL; CHOLINERGIC RECEPTOR STIMULATING AGENT; NITRIC OXIDE;

AFFINITY CHROMATOGRAPHY; ARTICLE; BREAST CANCER; CANCER CELL; CANCER STAGING; CELL PROLIFERATION; CELL STRAIN MCF 7; COLORIMETRY; CONTROLLED STUDY; GENE ACTIVATION; GENE EXPRESSION; HUMAN; HUMAN CELL; PRIORITY JOURNAL; PURIFICATION; SIGNAL TRANSDUCTION; BREAST NEOPLASMS; CARCINOMA; DISEASE COURSE; DRUG EFFECTS; FEMALE; IMMUNOLOGY; ISOLATION AND PURIFICATION; METABOLISM; PATHOLOGY; PATHOPHYSIOLOGY; TUMOR CELL LINE;

AUTOANTIBODIES; BREAST NEOPLASMS; CARBACHOL; CARCINOMA; CELL LINE, TUMOR; CELL PROLIFERATION; CHOLINERGIC AGONISTS; CHROMATOGRAPHY, AFFINITY; DISEASE PROGRESSION; FEMALE; HUMANS; IMMUNOGLOBULIN G; NEOPLASM STAGING; NITRIC OXIDE; NITRIC OXIDE SYNTHASE; RECEPTOR, MUSCARINIC M3; RECEPTOR, MUSCARINIC M4; SIGNAL TRANSDUCTION;

EID: 77953286011     PISSN: 02719142     EISSN: 15732592     Source Type: Journal    
DOI: 10.1007/s10875-010-9370-0     Document Type: Article

References (38)

1. M Jakóbisiak W Lasek J Golab 2003 Natural mechanisms protecting against cancer Immunol Lett 90 103 222 10.1016/j.imlet.2003.08.005 14687712 (Pubitemid 37548466)
2. T Boon JC Cerottini B Van Den Eynde P van der Bruggen A Van Pel 1994 Tumor antigens recognized by T lymphocytes Annu Rev Immunol 12 337 366 10.1146/annurev.iy.12.040194.002005 1:CAS:528:DyaK2cXivFKju70%3D 8011285
3. SS Witkin 2001 Heat shock protein expression and immunity: relevance to gynecologic oncology Eur J Gynaecol Oncol 22 249 256 1:STN:280: DC%2BD3MnktlKqtA%3D%3D 11695802
4. JC Antoine L Absi J Honnorat JM Boulesteix T de Brouker C Vial, et al. 1999 Antiamphiphysin antibodies are associated with various paraneoplastic syndromes and tumors Arch Neurol 56 151 152 10.1001/archneur.56.2.172 (Pubitemid 29076181)
5. F Fernandez Madrid RL Karvonen J Ensley M Kraut JL Granda H Alansari, et al. 2005 Spectra of antinuclear antibodies in patients with squamous cell carcinoma of the lung and of the head and neck Cancer Detect Prev 29 59 65 10.1016/j.cdp.2004.10.002 15734219 (Pubitemid 40283500)
6. MH Hansen H Nielsen HJ Ditzel 2001 The tumor infiltrating B cell response in medullary breast cancer is oligoclonal and directed against the autoantigen actin exposed on the surface of apoptotic cancer cells Proc Natl Acad Sci USA 98 12659 12664 10.1073/pnas.171460798 1:CAS:528:DC%2BD3MXotFaiu7g%3D 11606714 (Pubitemid 33020002)
7. RM Eglen 2005 Muscarinic receptor subtype: pharmacology and physiology Prog Med Chem 43 105 136 10.1016/S0079-6468(05)43004-0 1:CAS:528: DC%2BD2MXps1Citb0%3D 15850824 (Pubitemid 40605496)
8. K Peraza-Cruces L Gutiérrez-Guédez D Castañeda Perozo CR Lankford C Rodríguez-Bonfante R Bonfante-Cabarcas 2008 Trypanosoma cruzi infection induces up-regulation of cardiac muscarinic acetylcholine receptors in vivo and in vitro Braz J Med Biol Res 41 796 803 10.1590/S0100-879X2008000900009 1:CAS:528:DC%2BD1cXhtlyjtLnJ 18820770
9. HJ Koch S Haas T Jürgens 2005 On the physiological relevance of muscarinic acetylcholine receptors in Alzheimer's disease Curr Med Chem 12 2915 2921 10.2174/092986705774454742 1:CAS:528:DC%2BD2MXht1ShsrvF 16305479 (Pubitemid 41601564)
10. JA Sogn 1998 Tumor immunology: the glass is half full Immunity 9 757 763 10.1016/S1074-7613(00)80641-X 1:CAS:528:DyaK1MXms1CnsQ%3D%3D 9881966 (Pubitemid 29024455)
11. H Abken A Hombach C Heuser K Kronfeld B Seliger 2002 Tuning tumor-specific T-cell activation: a matter of costimulation? Trends Immunol 23 240 245 10.1016/S1471-4906(02)02180-4 1:CAS:528:DC%2BD38Xjtl2lt7c%3D 12102744 (Pubitemid 34499560)
12. L Paleari A Grozzio A Cesario P Russo 2008 The cholinergic system in cancer Semin Cancer Biol 18 211 217 10.1016/j.semcancer.2007.12.009 1:CAS:528:DC%2BD1cXlslGis7s%3D 18262434
13. AJ Español ME Sales 2004 Different muscarinic receptors are involved in the proliferation of murine mammary adenocarcinoma cell lines Int J Mol Med 13 311 319 14719140
14. G Fiszman V Cattaneo E de la Torre A Español LL Colombo E Sacerdote de Lustig, et al. 2006 Muscarinic receptors autoantibodies purified from mammary adenocarcinoma bearing mice sera stimulate tumor progression Int Immunopharmac 6 1323 1330 10.1016/j.intimp.2006.04.007 1:CAS:528: DC%2BD28XlvF2ktro%3D (Pubitemid 43868194)
15. TR Chen 1977 In situ detection of micoplasma contamination in cell cultures by fluorescent Hoechst 33258 stain Exp Cell Res 104 255 262 10.1016/0014-4827(77)90089-1 1:STN:280:DyaE2s7hsF2ltg%3D%3D 65285
16. MM Bradford 1976 A rapid and sensitive method for the quantification of microgram quantities of protein utilizing the principle of protein-dye binding Anal Biochem 72 248 254 10.1016/0003-2697(76)90527-3 1:CAS:528: DyaE28XksVehtrY%3D 942051
17. DL Granger JB Hibbs JR Perfect DT Durack 1990 Metabolic fate of L-arginine in relation to microbiostatic capability of murine macrophages J Clin Invest 85 264 273 10.1172/JCI114422 1:CAS:528:DyaK3cXhtlOhtb4%3D 2404026
18. AJ Español AM Eiján EO Mazzoni L Davel MA Jasnis ES Lustig, et al. 2002 Nitric oxide synthase, arginase and cyclooxygenase are involved in muscarinic receptors activation in different murine mammary adenocarcinoma cell lines Int J Mol Med 9 651 657 12011984
19. I Wessler E Roth C Deutsch P Brockerhoff F Bittinger CJ Kirkpatrick, et al. 2001 Release of non-neuronal acetylcholine from isolated human placenta is mediated by organic cation transporters Br J Pharmacol 134 951 956 10.1038/sj.bjp.0704335 1:CAS:528:DC%2BD3MXosVGrs7g%3D 11682442
20. N Shah S Khurana K Cheng JP Raufman 2009 Muscarinic receptors and ligands in cancer Am J Physiol Cell Physiol 296 221 232 10.1152/ajpcell.00514.2008
21. GL Fiszman ME Sales 2008 Antibodies against muscarinic receptors in breast cancer: agonizing tumor growth Curr Immunol Rev 4 1 7 10.2174/157339508785160732
22. CC Hernandez JH Nascimento EA Chaves PC Costa MO Masuda E Kurtenbach, et al. 2008 Autoantibodies enhance agonist action and binding to cardiac muscarinic receptors in chronic Chagas' disease J Recept Signal Transduct Res 28 375 401 10.1080/10799890802262319 1:CAS:528:DC%2BD1cXpvVSru7w%3D 18702010
23. Y Wu MT Li Y Zhao S Feng L Su Y Dong 2008 The clinical significance of autoantibodies against acetylcholine muscarinic 3 receptor in primary Sjögren's syndrome Zhonghua Nei Ke Za Zhi 47 563 565 1:CAS:528: DC%2BD1MXhtVantbvO 19035167
24. ME Sales AJ Español L Sterin-Borda E Borda MM de Bracco 1999 Protein kinase C regulates NO-cGMP pathway in muscarinic receptor activation by HIV+-IgA Int J Mol Med 3 633 637 1:CAS:528:DyaK1MXjvVCntLg%3D 10341295
25. F Fernández Madrid 2005 Autoantibodies in breast cancer sera: candidate biomarkers and reporters of tumorigenesis Cancer Lett 230 187 198 10.1016/j.canlet.2004.12.017 16297705 (Pubitemid 41612462)
26. W Schulze R Kunze G Wallukat 2005 Pathophysiological role of autoantibodies against G-protein-coupled receptors in the cardiovascular system Exp Clin Cardiol 10 170 172 1:CAS:528:DC%2BD2MXhtVOrtL%2FM 19641683
27. H Issafras S Angers S Bulenger C Blanpain M Parmentier C Labbé-Jullié, et al. 2002 Constitutive agonist-independent CCR5 oligomerization and antibody-mediated clustering occurring at physiological levels of receptors J Biol Chem 277 34666 36473 10.1074/jbc.M202386200 1:CAS:528:DC%2BD38Xnt1WitLc%3D 12089144
28. CL Williams 2003 Muscarinic signaling in carcinoma cells Life Sci 72 2173 2182 10.1016/S0024-3205(03)00080-8 1:CAS:528:DC%2BD3sXhs1Cltbg%3D 12628476 (Pubitemid 36300805)
29. P Song HS Sekhon XW Fu M Maier Y Jia J Duan, et al. 2008 Activated cholinergic signaling provides a target in squamous cell lung carcinoma Cancer Res 68 4693 4700 10.1158/0008-5472.CAN-08-0183 1:CAS:528:DC%2BD1cXnt1aqurg%3D 18559515
30. 3 muscarinic receptors attenuates murine colon epithelial cell proliferation and neoplasia Cancer Res 68 3573 3578 10.1158/0008-5472.CAN-07-6810 1:CAS:528:DC%2BD1cXlvVOit7w%3D 18483237
31. LE Rimmaudo E de la Torre E Sacerdote de Lustig ME Sales 2005 Muscarinic receptors are involved in LMM3 tumor cell proliferation and angiogenesis Biochim Biophys Res Comun 334 1360 1365
32. MJ O'Shaughnessy ZM Chen I Gramaglia PA Taylor A Panoskaltsis-Mortari C Vogtenhuber, et al. 2007 Elevation of intracellular cyclic AMP in alloreactive CD4(+) T cells induces alloantigen-specific tolerance that can prevent GVHD lethality in vivo Biol Blood Marrow Transplant 13 530 542 10.1016/j.bbmt.2007. 01.071 17448912 (Pubitemid 46585930)
33. F Chiaradonna C Balestrieri D Gaglio M Vanoni 2008 Ras and PKA pathways in cancer: new insight from transcriptional analysis Front Biosci 13 5257 5278 10.2741/3079 1:CAS:528:DC%2BD1cXnsVOjtb0%3D 18508585
34. NM Nathanson 2000 A multiplicity of muscarinic mechanisms: enough signaling pathways to take your breath away PNAS 97 6245 6247 10.1073/pnas.97.12.6245 1:CAS:528:DC%2BD3cXktFWqurc%3D 10841527 (Pubitemid 30412696)
35. K Elkon P Casali 2008 Nature and functions of autoantibodies Nat Clin Pract Rheumatol 4 491 498 10.1038/ncprheum0895 1:CAS:528:DC%2BD1cXhtVGgsb7F 18756274
36. JR Lancaster K Xie 2006 Tumors face NO problems? Cancer Res 66 6459 6462 10.1158/0008-5472.CAN-05-2900 1:CAS:528:DC%2BD28XmsVamsbo%3D 16818612 (Pubitemid 44085595)
37. S Reina L Sterin-Borda B Orman E Borda 2004 Human mAChR antibodies from Sjögren syndrome sera increase cerebral nitric oxide synthase activity and nitric oxide synthase mRNA level Clin Immunol 113 193 202 10.1016/j.clim.2004. 08.005 1:CAS:528:DC%2BD2cXnvVyrurs%3D 15451477 (Pubitemid 39296853)
38. DK Waid M Chell EE El-Fakahany 2000 M(2) and M(4) muscarinic receptor subtypes couple to activation of endothelial nitric oxide synthase Pharmacology 61 37 42 10.1159/000028378 1:CAS:528:DC%2BD3cXlsFalt70%3D 10895079